Sugar-Induced Modification of Fibroblast Growth Factor 2 Reduces Its Angiogenic Activity in Vivo

American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)64209-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Oligomerization Reduces Heparin Affinity but Enhances Receptor Binding of Fibroblast Growth Factor 2

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2000English

Elevated Levels of the Angiogenic Cytokines Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Sera of Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
1997English

Diacetyloxyl Derivatization of the Fibroblast Growth Factor Inhibitor Dobesilate Enhances Its Anti-Inflammatory, Anti-Angiogenic and Anti-Tumoral Activities

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Fibroblast Growth Factor 2 Modulates Hippocampal Microglia Activation in a Neuroinflammation Induced Model of Depression

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2018English

Positive Correlation Between Estradiol and Vascular Endothelial Growth Factor but Not Fibroblast Growth Factor-2 in Normal Human Breast Tissue in Vivo

Clinical Cancer Research
Cancer ResearchOncology
2005English

AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor

Clinical Cancer Research
Cancer ResearchOncology
2007English

Heparan Sulphate Glycosaminoglycans Derived From Endothelial Cells and Smooth Muscle Cells Differentially Modulate Fibroblast Growth Factor-2 Biological Activity Through Fibroblast Growth Factor Receptor-1

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2003English

Injectable Fibroblast Growth Factor-2 Coacervate for Persistent Angiogenesis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

The Oncometabolite D‑2‑hydroxyglutarate Induces Angiogenic Activity Through the Vascular Endothelial Growth Factor Receptor 2 Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy